Literature DB >> 20701101

DNA ploidy, E-cadherin, beta-catenin expression and their clinicopathologic significance in imprints of non-small cell lung cancer.

George Chelidonis1, Nikolaos Kavantzas, Efstratios Patsouris, Eumorfia Pagaki, Anna-Maria Athanasiadou, George Agrogiannis, Pauline Athanasiadou.   

Abstract

OBJECTIVE: To evaluate, in imprints of resected non-small cell lung cancers (NSCLCs), the relationship between DNA ploidy and E-cadherin/beta-catenin expression with classical prognostic factors. STUDY
DESIGN: A total of 45 patients (28 squamous cell carcinomas and 17 adenocarcinomas) who underwent surgical treatment for NSCLC were examined with immunocytochemistry for the expression of E-cadherin/ beta-catenin imprint smears, which also were stained using the Thionin Feulgen procedure in order to evaluate DNA ploidy in the same cases.
RESULTS: Thirty-two (71.1%) of the tumors were classified as aneuploid. E-cadherin-positive expression was observed in 18 (40%) and p-catenin in 21 (46.7%) of the tumors. We found a significant relationship between DNA ploidy and grade (p= 0.005). E-cadherin and beta-catenin expression correlated with grade (p < 0.0001 for both) and also with nodal status (p = 0.004 and p = 0.017, respectively). The mean DNA index was higher for tumors with negative expression of E-cadherin/beta-catenin (p = 0.045 and p = 0.025, respectively).
CONCLUSION: DNA aneuploidy correlates with poor and moderately differentiated tumors. E-cadherin- and beta-catenin-positive expression is in relation to well-differentiated carcinomas and nodal metastasis. The relationship between DNA ploidy and E-cadherin/beta-catenin needs to be further investigated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20701101

Source DB:  PubMed          Journal:  Anal Quant Cytol Histol        ISSN: 0884-6812            Impact factor:   0.302


  6 in total

1.  Clinicopathologic significance of β-catenin and matrix metalloproteinase-2 expression in non-small cell lung cancer.

Authors:  Guang-Hu Li; Yong-Sheng Cui; Qi-Yu Wu; Xiong-Ji Zhang; Yu-Fei Gao
Journal:  Med Oncol       Date:  2013-01-05       Impact factor: 3.064

2.  The Prognostic Influence of BRAF Mutation and other Molecular, Clinical and Laboratory Parameters in Stage IV Colorectal Cancer.

Authors:  Maria L Karadima; Angelica A Saetta; Ilenia Chatziandreou; Andreas C Lazaris; Efstratios Patsouris; Nikolaos Tsavaris
Journal:  Pathol Oncol Res       Date:  2016-03-31       Impact factor: 3.201

3.  Survival in patients with stage IV noncardia gastric cancer - the influence of DNA ploidy and Helicobacter pylori infection.

Authors:  John Syrios; Stavros Sougioultzis; Ioannis D Xynos; Nikolaos Kavantzas; Christos Kosmas; George Agrogiannis; John Griniatsos; Ioannis Karavokyros; Emmanouil Pikoulis; Efstratios S Patsouris; Nikolas Tsavaris
Journal:  BMC Cancer       Date:  2012-06-21       Impact factor: 4.430

4.  [Significance of epithelial-mesenchaymal transition phenotype in invasive tumor front cells of lung squamous cell carcinoma].

Authors:  Yinghua Song; Caiqing Zhang; Zhixin Cao; Jiawen Xu; Lingcheng Wang; Xiaoyan Lin
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2014-04

5.  Mesenchymal Stem Cells and their Derived Exosomes Promote Malignant Phenotype of Polyploid Non-Small-Cell Lung Cancer Cells through AMPK Signaling Pathway.

Authors:  Lili Wang; Mingyue Ouyang; Sining Xing; Song Zhao; Shuo Liu; Lingyan Sun; Huiying Yu
Journal:  Anal Cell Pathol (Amst)       Date:  2022-04-04       Impact factor: 2.916

6.  Factors Influencing Survival in Stage IV Colorectal Cancer: The Influence of DNA Ploidy.

Authors:  Ioannis D Xynos; Nicolaos Kavantzas; Smaro Tsaousi; Michalis Zacharakis; George Agrogiannis; Christos Kosmas; Andreas Lazaris; John Sarantonis; Stavros Sougioultzis; Dimitrios Tzivras; Aris Polyzos; Efstratios S Patsouris; Nikolas Tsavaris
Journal:  ISRN Gastroenterol       Date:  2013-06-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.